Saikosaponin D exhibits anti-leukemic activity by targeting FTO/m6A signaling

A RNA methylation mediated the anti-leukemic actions of SsD, thereby opening a window to develop SsD as an epitranscriptome-base drug for leukemia therapy.

Saikosaponin D exhibits anti-leukemic activity by targeting FTO/m6A signaling | Litlas